CT (Lux) Sustainable Opportunities European Equity F Acc EURRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 18.1 | -12.7 | 16.4 | 5.2 | |
+/-Cat | - | 2.8 | -4.4 | 4.9 | 0.5 | |
+/-B’mrk | - | 0.5 | -8.1 | 3.3 | 0.0 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 02/05/2024 | EUR 14.33 | |
Day Change | -0.17% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU1438421858 | |
Fund Size (Mil) 02/05/2024 | EUR 14.89 | |
Share Class Size (Mil) 02/05/2024 | EUR 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 10/02/2023 | 0.50% |
Investment Objective: CT (Lux) Sustainable Opportunities European Equity F Acc EUR |
The investment objective of the Portfolio is to achieve long-term capital appreciation through sustainable investments. The Portfolio invests in European companies listed on one of the European States Stock Exchanges or a regulated market. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Moss 01/06/2012 | ||
Inception Date 18/08/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CT (Lux) Sustainable Opportunities European Equity F Acc EUR | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 6.53 |
ASML Holding NV | Technology | 5.65 |
SAP SE | Technology | 5.33 |
Schneider Electric SE | Industrials | 4.94 |
AstraZeneca PLC | Healthcare | 4.11 |
Increase Decrease New since last portfolio | ||
CT (Lux) Sustainable Opportunities European Equity F Acc EUR |